Skip to main content
. 2008 Nov;3(6):1669–1675. doi: 10.2215/CJN.02100508

Table 1.

Baseline characteristics, compared by target hemoglobin levela

Variable Target 9.5 to 11.5 g/dln = 300 Target 13.5 to 14.5 g/dln = 296 P
Hemoglobin (g/dl) 11.0 (10.8, 11.1) 11.0 (10.9, 11.2) 0.54
Epoetin dose (units per week) 6183 (5698, 6667) 7009 (6528, 7490) 0.02
Transferrin saturation (%) 36.8 (34.9, 38.8) 35.8 (33.8, 37.7) 0.44
Age 49.4 (47.7, 51.2) 52.2 (50.4, 53.9) 0.03
Female sex (%) 39.7 39.5 0.97
Race 0.24
    White 87.7 91.2
    Black 5.7 4.4
    Asian 4.3 1.7
    other 2.3 2.7
Dialysis duration (months) 10.2 (9.6, 10.8) 10.0 (9.4, 10.5) 0.58
Body mass index (kg/m2) 26.3 (25.7, 26.9) 26.5 (25.9, 27.1) 0.78
Country (%)
    Austria 3.0 4.1
    Belgium 3.3 4.7
    Canada 32.0 27.7
    France 3.0 2.7
    Germany 11.0 12.5
    Greece 2.3 1.4
    Hungary 10.7 12.2
    Poland 22.3 22.6
    Spain 3.0 3.0
    United Kingdom 9.3 9.1
Primary cause of renal disease 0.54
    glomerulonephritis 29.0 28.4
    diabetes 16.7 18.9
    hypertension 9.3 6.8
    polycystic kidney disease 7.7 10.5
    other/unknown 37.3 35.5
Dialysis access (%) 0.21
    fistula 82.7 85.8
    graft 5.0 6.1
    catheter 12.3 8.11
Serum albumin (mg/dl) 4.0 (3.9, 4.0) 4.0 (3.9, 4.0) 0.88
a

Data are reported either as percent or as means (95% confidence intervals). The χ2 test and analysis of variance were used for between-target comparisons.